These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7972961)

  • 1. Physiologically based pharmacokinetic models in developmental toxicology.
    O'Flaherty EJ
    Risk Anal; 1994 Aug; 14(4):605-11. PubMed ID: 7972961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological "constants" for PBPK models for pregnancy.
    Young JF; Branham WS; Sheehan DM; Baker ME; Wosilait WD; Luecke RH
    J Toxicol Environ Health; 1997 Dec; 52(5):385-401. PubMed ID: 9388532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computer model and program for xenobiotic disposition during pregnancy.
    Luecke RH; Wosilait WD; Pearce BA; Young JF
    Comput Methods Programs Biomed; 1997 Jul; 53(3):201-24. PubMed ID: 9230455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy.
    Andrew MA; Hebert MF; Vicini P
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5454-7. PubMed ID: 19163951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
    Andersen ME
    Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.
    Mitani GM; Steinberg I; Lien EJ; Harrison EC; Elkayam U
    Clin Pharmacokinet; 1987 Apr; 12(4):253-91. PubMed ID: 3297463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiologically based pharmacokinetic computer model for human pregnancy.
    Luecke RH; Wosilait WD; Pearce BA; Young JF
    Teratology; 1994 Feb; 49(2):90-103. PubMed ID: 8016750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat.
    Gabrielsson JL; Paalzow LK; Nordström L
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):149-65. PubMed ID: 6491898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice.
    Ward KW; Blumenthal GM; Welsch F; Pollack GM
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):311-22. PubMed ID: 9266804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug kinetics in pregnancy.
    Krauer B; Krauer F
    Clin Pharmacokinet; 1977; 2(3):167-81. PubMed ID: 328205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat.
    Clewell RA; Merrill EA; Yu KO; Mahle DA; Sterner TR; Mattie DR; Robinson PJ; Fisher JW; Gearhart JM
    Toxicol Sci; 2003 Jun; 73(2):235-55. PubMed ID: 12700398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.
    Alsmadi MM; Idkaidek N
    Curr Drug Metab; 2018; 19(12):972-978. PubMed ID: 29962340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.
    Lin Z; Fisher JW; Wang R; Ross MK; Filipov NM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):140-58. PubMed ID: 23958493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in the developing rabbit brain.
    Kim CS; Binienda Z; Sandberg JA
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):250-9. PubMed ID: 8619233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat.
    Emond C; Birnbaum LS; DeVito MJ
    Toxicol Sci; 2004 Jul; 80(1):115-33. PubMed ID: 15056810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomonitoring of human fetal exposure to environmental chemicals in early pregnancy.
    Cooke GM
    J Toxicol Environ Health B Crit Rev; 2014; 17(4):205-24. PubMed ID: 24828452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition kinetics in the rat fetus.
    Nanbo T
    Reprod Toxicol; 1991; 5(5):411-6. PubMed ID: 1806150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologically based pharmacokinetic model for methyl mercury in the pregnant rat and fetus.
    Gray DG
    Toxicol Appl Pharmacol; 1995 May; 132(1):91-102. PubMed ID: 7747289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perchlorate and radioiodide kinetics across life stages in the human: using PBPK models to predict dosimetry and thyroid inhibition and sensitive subpopulations based on developmental stage.
    Clewell RA; Merrill EA; Gearhart JM; Robinson PJ; Sterner TR; Mattie DR; Clewell HJ
    J Toxicol Environ Health A; 2007 Mar; 70(5):408-28. PubMed ID: 17454566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
    Dixit R; Riviere J; Krishnan K; Andersen ME
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.